Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Juno Pharmaceuticals Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (255)
Cancellation by sponsor (83)
Prescription medicine registration (28)
Section 14, TGO91 consent (6)
Australian public assessment report (AusPar) (1)
Prescription medicine decision summary (1)

Date

2026 (5)
2025 (23)
2024 (13)
2023 (11)
2022 (35)
2021 (68)
2020 (45)
2019 (51)
2018 (18)
2017 (14)
2016 (17)
2015 (13)
2014 (7)
2013 (8)
2012 (12)
2011 (5)
2010 (1)
2009 (2)
2007 (1)
2006 (4)
2003 (7)
2000 (1)
1999 (2)
1998 (1)
1996 (3)
1994 (2)
1991 (5)

Search

Sponsor content

374 result(s) found, displaying 21 to 30

ASTRAZENECA FENTANYL 500 microgram/10mL (as citrate) injection ampoule Cancelled under Section 30(1)(c) of the Act

12 May 2025

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
ASTRAZENECA FENTANYL 100 microgram/2mL (as citrate) injection ampoule Cancelled under Section 30(1)(c) of the Act

12 May 2025

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
ASTRAZENECA ATROPINE SULFATE 1.2mg/1mL injection BP ampoule Cancelled under Section 30(1)(c) of the Act

12 May 2025

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
ASTRAZENECA ATROPINE SULFATE 600 microgram/1mL injection BP ampoule Cancelled under Section 30(1)(c) of the Act

12 May 2025

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
ASTRAZENECA ATROPINE SULFATE 400 microgram/1mL injection BP ampoule Cancelled under Section 30(1)(c) of the Act

12 May 2025

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
ASTRAZENECA ATROPINE SULFATE 500 microgram/1mL injection BP ampoule Cancelled under Section 30(1)(c) of the Act

12 May 2025

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
DOUGLAS PIPERACILLIN 4g (as sodium) powder for injection Cancelled under Section 30(1)(c) of the Act

11 April 2025

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
DOUGLAS PIPERACILLIN 2g (as sodium) powder for injection vial Cancelled under Section 30(1)(c) of the Act

11 April 2025

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
DOUGLAS PIPERACILLIN 1g (as sodium) powder for injection vial Cancelled under Section 30(1)(c) of the Act

11 April 2025

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
EXARANE enoxaparin sodium 40mg/0.4mL solution for injection prefilled syringe with safety lock system (429090)

13 May 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for EXARANE enoxaparin sodium 40mg/0.4mL solution for injection prefilled syringe with safety lock system.

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.